Search Browse Earnings

Allakos Inc. — SlamSEC

Allakos Inc.

Pharmaceutical Preparations·SAN DIEGO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$189.9M

FY 2024

Net Income

-$185.7M

FY 2024

EPS (Diluted)

-$2.14

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$66.4M

FY 2024

Total Debt

—

Net Cash

$66.4M

Enterprise Value

—

Debt / EBITDA

0.3x

FY 2024

EV / EBITDA

—

Employees

—

CFO

Radford Harlan Baird